Advanced Search

License Type

Rights Holder

Asset Type

Subtype

Add additional filters to further refine your search

Add filter

Display Sensitive Materials

Journal Article Title

Search Results

Displaying assets from 1 to 30 out of 6

/assets?dynamic_filters%5Barticle_title%5D=Cetuximab%E2%80%90conjugated+nanodiamonds+drug+delivery+system+for+enhanced+targeting+therapy+and+3D+Raman+imaging&template=grid

- Identifier
- jbio201700011-fig-0002
- License Type
- Rights Managed
- Rights Holder
- John Wiley & Sons, Inc.
Description Cell viability assessment. (A) HepG2 cells were first incubated with DMEM (control), bare NDs (100 μg/ mL), cetuximab‐NDs (100 μg/mL), CNC (100 μg/mL) and cisplatin (1.2 μg/mL, the concentration is...
Article Title: Cetuximab‐conjugated nanodiamonds drug delivery system for enhanced targeting therapy and 3D Raman imaging
Publication Title: Journal of Biophotonics

Add to Cart
- Identifier
- jbio201700011-fig-0005
- License Type
- Rights Managed
- Rights Holder
- John Wiley & Sons, Inc.
Description Enhanced endocytosis of cetuximab‐NDs‐cisplatin (CNC) conjugate into HepG2 cells in comparison to NDs‐cisplatin (NC) and EGF‐NDs‐cisplatin (ENC) with 3D Raman imaging. A1, B1 and C1: The bright...
Article Title: Cetuximab‐conjugated nanodiamonds drug delivery system for enhanced targeting therapy and 3D Raman imaging
Publication Title: Journal of Biophotonics

Add to Cart
- Identifier
- jbio201700011-fig-0001
- License Type
- Rights Managed
- Rights Holder
- John Wiley & Sons, Inc.
Description Fabrication and characterization of cetuximab‐NDs‐cisplatin bioconjugate. (A) Synthetic scheme of cetuximab‐NDs‐cisplatin bioconjugate. NDs were carboxylated first and then functionalized with...
Article Title: Cetuximab‐conjugated nanodiamonds drug delivery system for enhanced targeting therapy and 3D Raman imaging
Publication Title: Journal of Biophotonics

Add to Cart
- Identifier
- jbio201700011-fig-0003
- License Type
- Rights Managed
- Rights Holder
- John Wiley & Sons, Inc.
Description Enhanced therapeutic efficacy of cetuximab‐NDs‐cisplatin (100 μg/mL) on HepG2 cells in comparison with NDs‐cisplatin and EGF‐NDs‐cisplatin. HepG2 cells incubated in DMEM only was taken as control....
Article Title: Cetuximab‐conjugated nanodiamonds drug delivery system for enhanced targeting therapy and 3D Raman imaging
Publication Title: Journal of Biophotonics

Add to Cart
- Identifier
- jbio201700011-fig-0004
- License Type
- Rights Managed
- Rights Holder
- John Wiley & Sons, Inc.
Description 3D Raman imaging of a HepG2 cell incubated with NDs at the concentration of 25 μg/mL for 4 h and following another 48 h recovery in fresh media. (A) Bright field image and Raman images of the HepG2...
Article Title: Cetuximab‐conjugated nanodiamonds drug delivery system for enhanced targeting therapy and 3D Raman imaging
Publication Title: Journal of Biophotonics

Add to Cart
- Identifier
- jbio201700011-fig-0006
- License Type
- Rights Managed
- Rights Holder
- John Wiley & Sons, Inc.
Description Visualization of the morphology change of HepG2 cells treated with NDs‐cisplatin (NC), EGF‐NDs‐cisplatin (ENC) and cetuximab‐NDs‐cisplatin (CNC) conjugate by Raman imaging. A1, B1 and C1: The...
Article Title: Cetuximab‐conjugated nanodiamonds drug delivery system for enhanced targeting therapy and 3D Raman imaging
Publication Title: Journal of Biophotonics

Add to Cart